<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02297633</url>
  </required_header>
  <id_info>
    <org_study_id>BJCYYT-12345</org_study_id>
    <nct_id>NCT02297633</nct_id>
  </id_info>
  <brief_title>Evaluation of Reactive Oxygen Metabolites in the Value of COPD</brief_title>
  <official_title>System Evaluation of Reactive Oxygen Metabolites in the Value of Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study through the long-term observation followed up for 2 years to find the change of
      the COPD patients blood ROMs, systematically evaluate the relationship between ROMs and the
      severity of COPD. Evaluate the differences of prognosis between the different oxidative
      stress level (according to the level of ROMs are divided into higher and normal phenotype).
      Explore the new oxidative stress evaluation index ROMs application value in COPD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reactive oxygen metabolites (reactive oxygen metabolites, ROMs) test is a method by measuring
      the total reactive oxygen metabolites (ROMs) content in blood so as to evaluate the overall
      level of oxidative stress in the human body .Our previous studies have established the method
      of detecting ROMs which is suitable for fully automatic biochemical analyser.Our study
      through the long-term observation followed up for 2 years to find the change of the COPD
      patients blood ROMs, systematically evaluate the relationship between ROMs and the severity
      of COPD. Evaluate the differences of prognosis between the different oxidative stress level
      (according to the level of ROMs are divided into higher and normal phenotype). Explore the
      new oxidative stress evaluation index ROMs application value in COPD.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The different levels of the ROMs among different groups</measure>
    <time_frame>3 years</time_frame>
    <description>Apply the analysis of variance to compare the different levels of ROMs among the four different groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The differences of the ROMs among the different lung function levels in the stable stage of COPD group</measure>
    <time_frame>3 years</time_frame>
    <description>Apply the analysis of variance to compare the differences of the ROMs among the lung function levels in the stable stage of COPD group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relevance of the ROMs with the lung function levels in the stable stage of COPD group</measure>
    <time_frame>3 years</time_frame>
    <description>Apply Pearson correlation to compare relevance the of the ROMs with the lung function levels in the stable stage of COPD group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relevance of the ROMs with the score of mMRC in the stable stage of COPD group</measure>
    <time_frame>3 years</time_frame>
    <description>Apply Pearson correlation to compare relevance the of the ROMs with score of mMRC in the stable stage of COPD group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relevance of the ROMs with the score of CAT in the stable stage of COPD group</measure>
    <time_frame>3 years</time_frame>
    <description>Apply Pearson correlation to compare relevance the of the ROMs with score of CAT in the stable stage of COPD group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relevance of the ROMs with the numbers of exacerbation in the stable stage of COPD group</measure>
    <time_frame>3 years</time_frame>
    <description>Apply Pearson correlation to compare relevance the of the ROMs with numbers of exacerbation in the stable stage of COPD group.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>COPD(Chronic Obstructive Pulmonary Disease)</condition>
  <arm_group>
    <arm_group_label>Stability in patients with COPD</arm_group_label>
    <description>Those patients diagnosed COPD according to the GOLD guideline and without acute exacerbation within one month.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AECOPD</arm_group_label>
    <description>the diagnosis of an exacerbation relies exclusively on the clinical presentation of the patient complaining of an acute change of symptoms (baseline dyspnea, cough, and/or sputum production) that is beyond normal day-to-day variation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy persons without smoking</arm_group_label>
    <description>The healthy people who do not smoke</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy persons with smoking</arm_group_label>
    <description>Healthy persons who smoke</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Chaoyang hospital clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of COPD according to GOLD 2013

        Exclusion Criteria:

          -  A history of asthma or other chronic lung diseases Take Antioxidant therapy There are
             new or recurrent symptomatic myocardial ischemia, severe arrhythmia, cardiac
             insufficiency cerebrovascular disease Senile dementia or cognitive impairment cancer
             Severe liver and kidney and other viscera function insufficiency Language
             communication barriers Limb activity disorder The last 3 months participated in sports
             training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ting Yang, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Respiratory Institute, Beijing chaoyang hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ting Yang, Doctor</last_name>
    <phone>13651380809</phone>
    <email>dryangting@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jie Liu, Master</last_name>
    <phone>18811225394</phone>
    <email>chaoyangliujie@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Respiratory Institute;Beijing chaoyang hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ting Yang, Doctor</last_name>
      <phone>13651380809</phone>
      <email>dryangting@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>Jie Liu, Master</last_name>
      <phone>18811225394</phone>
      <email>chaoyangliujie@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xiaoning Bu, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hong Zhang, Master</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaohong Chang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Baomei Wu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jingyu Quan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jie Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Huimin Gong</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hongyan Pang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2014</study_first_posted>
  <last_update_submitted>November 19, 2014</last_update_submitted>
  <last_update_submitted_qc>November 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Jie liu</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>reactive oxygen metabolites</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

